ILL hosts massive anti-rabies vaccine drive on World Zoonosis Day 2022

IMT News Desk
IMT News Desk
· 2 min read

Administers one lakh free vaccines in nationwide vaccination camps

Indian Immunologicals Limited (IIL) organised a nationwide free vaccination camp against zoonotic diseases on account of World Zoonosis Day 2022. Diseases that transmit from animals to human beings are called Zoonotic diseases. World Zoonosis Day is celebrated annually on July 6 to honour the first immunisation against a zoonotic illness. It holds substantial significance in educating and raising awareness about zoonotic diseases.

Indian Immunologicals has administered one lakh doses of Raksharab and Starvac R (Anti-rabies vaccines of IIL) free of cost, in an endeavour to realise its vision of ‘One health’, a collaborative effort towards optimal health for humans and animals through its innovative healthcare products.

In their fight against the spread of such zoonotic viruses, IIL’s vaccination camp was escalated to 100 cities across the country through veterinary dispensaries, veterinary colleges and NGOs.

Speaking on World Zoonosis Day, Dr K Anand Kumar, MD, ILL said, “It is the commitment of IIL as a truly One Health company to bring cost-effective vaccines in both animal and human health. Through our “Anti-Rabies vaccine drive”, we aim to spread awareness of the disease and the need to restrain it. Apart from Raksharab and Starvac R, IIL has the largest range of zoonotic vaccines in the country such as CYSVAX, Bruvax, and we are constantly innovating novel vaccines to cater to the ever-emerging zoonotic risks.”

Read Next

‘One Nation, One Emergency Helpline’ Proposal for Stroke Care Gains Momentum at FICCI Meet
News
April 16, 2026

‘One Nation, One Emergency Helpline’ Proposal for Stroke Care Gains Momentum at FICCI Meet

India’s stroke crisis demands urgent action, and the Indian Stroke Association (ISA) is leading the charge with a bold proposal for a unified national helpline. The ISA presented a comprehensive plan to strengthen stroke care delivery at a FICCI-hosted meeting attended by policymakers, healthcare leaders, and clinical experts. The plenary session, “Strengthening Stroke Care Delivery,” […]
Article by: IMT News Desk
Ivory raises fresh capital to strengthen deep tech offerings
News
April 16, 2026

Ivory raises fresh capital to strengthen deep tech offerings

Ivory, a brain health platform focused on early cognitive screening, has raised $1M in fresh funding, onboarding new investors to deepen its product, clinical and IP capabilities. The round saw participation from Draper Associates, a global venture capital firm with a strong focus on biotech and healthtech, along with SAGE Venture Fund, an AIF fund launched […]
Article by: IMT News Desk
Rubicon Research Enters Indian CNS Formulations Market with Strategic Acquisition
News
April 16, 2026

Rubicon Research Enters Indian CNS Formulations Market with Strategic Acquisition

Rubicon Research Limited today announced the acquisition of an 85% equity ownership in Arinna Lifesciences Limited from its current shareholders. With a portfolio of over 60 brands in chronic therapies, Arinna is one of the few domestic formulation companies principally focused on drugs treating conditions of the central nervous system (“CNS”) with more than 4,000 […]
Article by: IMT News Desk
MSN Laboratories Launches ‘SEMABEST, the First Integrated Made-in-India Semaglutide
News
April 16, 2026

MSN Laboratories Launches ‘SEMABEST, the First Integrated Made-in-India Semaglutide

MSN Laboratories has launched SEMABEST, its semaglutide brand, in the Indian market following approval from the Central Drugs Standard Control Organisation (CDSCO). SEMABEST is priced at nearly 50% lower than the innovator drug, significantly improving affordability and patient access. The therapy is available as a pre-filled pen for subcutaneous administration. In this evolving landscape, SEMABEST […]
Article by: IMT News Desk